News New sales reporting structure introduced. 2020 organic sales growth outlook now expected at 0%, from previously -2% to +2% Staff December 11, 2020 Please read the full announcement in PDF Attachment 2020_64_New_segment_reporting Iframe sync Post navigation Previous: Rhythm Pharmaceuticals Announces Appointments of Camille L. Bedrosian, M.D., and Lynn Tetrault, J.D., to its Board of DirectorsNext: Assure Holdings Announces Results of Annual General and Special Meeting of Shareholders More Stories Clinical Trial COVID-19 News Vaccine Vaxxas Secures TGA Licence to Manufacture Therapeutic Goods Staff December 14, 2025 Cancer Clinical Trial News Pharmaceutical InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial Staff December 14, 2025 Healthcare News Pharmaceutical President Trump’s Cannabis Decision Is Coming – And Why MMJ International Holdings Wins Either Way Staff December 13, 2025
